Merck and Selvita form oncology partnership
November 2, 2015Research and Development, Sales and Marketing Merck, Selvita, collaboration, oncology
Merck has entered a three-year agreement with Selvita to validate new therapeutic concepts in the field of oncology. The aim …
AbbVie reports 26% rise in Q3 revenues
October 30, 2015Sales and Marketing AbbVie, Humira
AbbVie has announced stronger-than-anticipated Q3 financial results, its revenues increasing 26.2% on the same period last year to $5.944 billion, …
The pharmaceutical ethics of drug-price increases
October 30, 2015Medical Communications, Research and Development Drug pricing, Turing Pharma, ethics
What is an ‘ethical’ price for a drug?Last month Turing Pharmaceuticals, a start-up run by a former hedge-fund manager, raised …
FDA approves new therapy for pancreatic cancer
October 30, 2015Medical Communications, Sales and Marketing FDA, Pancreatic cancer
The FDA has approved drug a pancreatic cancer drug, Onivyde, which has produced significant overall survival rates in an international …
Valeant drops Philidor after prescription fraud row
October 30, 2015Medical Communications, Sales and Marketing Valeant
Valeant has announced that it is ‘severing all ties with Philidor’, the specialty pharmacy at the heart of recent controversy surrounding …
NHS set for digital health tech review
October 30, 2015Medical Communications Jeremy Hunt, NHS, Robert Wachter, digital health, health secretary
Health secretary Jeremy Hunt says turning the NHS into a “patient-powered, technologically advanced health service” is “one of the most …
Digital software shows benefit in ADHD trial
October 30, 2015Medical Communications ADHD, Akili, PureTech Health, attention deficit hyperactivity disorder, digital tech
A pilot study of a digital health technology designed to improve symptoms of attention deficit hyperactivity disorder (ADHD) in children …
Sanofi recalls allergy injection pens
October 29, 2015Manufacturing and Production Allerject, Sanofi, anaphylaxis
Sanofi has halted manufacturing and is recalling its Allerject auto-injectors following a blunder involving incorrect dosages. The voluntary recall involves …
Alvogen appoints Faysal Kalmoua as EVP of portfolio
October 29, 2015Medical Communications Alvogen, Faysal Kalmoua
Alvogen has announced the appointment of Faysal Kalmoua as its new executive vice president of portfolio.Kalmoua joins Alvogen with an …
Allergan acquires rights to pioneering IBS treatment from Almirall
October 29, 2015Medical Communications, Sales and Marketing Allergan, Constella, IBS, linaclotide
Allergan and its commercialisation partner Ironwood Pharmaceuticals have announced that Allergan has acquired the rights to Constella.The companies have acquired …
ANALYSIS: The challenges of forecasting biosimilar sales across Europe
October 29, 2015Manufacturing and Production, Research and Development, Sales and Marketing biologics, biosimilars, generics, patent cliff, patents, sales, sales forecasts
The introduction of biologic medicines revolutionised treatment in several key therapeutic areas, including oncology, diabetes and various inflammatory diseases.The landscape …
FDA approves Bristol-Myers Squibb’s skin cancer drug
October 29, 2015Sales and Marketing BMS, Bristol-Myers Squibb, Yervoy, ipilumumab, melanoma
The FDA has recommended Bristol-Myers Squibb’s cancer drug Yervoy (ipilimumab) for the adjuvant treatment of patients with melanoma. The drug, …
Novo Nordisk posts strong nine-month results
October 29, 2015Sales and Marketing Novo Nordisk, insulin
Novo Nordisk has exceeded market expectations in its nine-month financial results, reporting a 51% increase in operating profit and 33% …
Bayer posts strong earnings growth
October 29, 2015Manufacturing and Production, Research and Development, Sales and Marketing
Sales across the Bayer group rose by 1.9% in the third quarter of 2015 to €11 billion, according the company’s …
Novartis launches new hypertension program in Ghana
October 29, 2015Research and Development
The Novartis Foundation and its partners have begun screening patients in a Community-based Hypertension Improvement Project (ComHIP) in Ghana in …
Pfizer in ‘friendly’ merger talks with Allergan
October 29, 2015Sales and Marketing Actavis, Allergan, Pfizer, Teva
Pfizer is in talks with Allergan over what could be the largest takeover deal in an already record-breaking year, it …
Baxter names José Almeida chairman and chief executive
October 29, 2015Manufacturing and Production, Research and Development, Sales and Marketing Joe Almeida, José Almeida, baxter
Baxter has named José (Joe) Almeida as the company’s new chairman and chief executive from January 1, 2016. Almeida will …
Dr Jane Osbourn to join BIA board as chair
October 28, 2015Dr Jane Osbourn, the vice president of research and development at MedImmune, will be the new chair of the BIA …
FDA approves first-in-class Amgen melanoma drug
October 28, 2015Research and Development, Sales and Marketing Amgen, Imlygic, melonoma
The US Food and Drug Administration (FDA) has approved Amgen’s Imlygic for the treatment of melanoma lesions in the skin …
Otsuka kidney drug earns first NICE nod
October 28, 2015Research and Development, Sales and Marketing NHS, NICE, jinarc, kidney disease, tolvaptan
NICE has released final guidance recommending Otsuka’s Jinarc, the first-ever treatment shown to slow progression of life-threatening Autosomal Dominant Polycystic …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
